Bernard Moss

USPTO Granted Patents = 44 (Patent Applications = 3)

CIPO Patents = 4

EPO Patents = 10 (Patent Applications = 10)

Average Co-Inventor Count = 3.3

ph-index = 13

Forward Citations = 417(Granted Patents)

Company Filing History:

23 out of 3,566

The United States of America, as Represented by the Secretary, Department of Health and Human Services

patents

9 out of 1,217

The United States of America as Represented by the Department of Health

The United States of America as Represented by the Secretary of

patents

5. 3 out of 254

The United States of America

patents

6. 2 out of 2,569

University of Pennsylvania

patents

7. 1 out of 2,936

University of Florida Research Foundation Inc

patents

8. 1 out of 12

The Government of the United States of America

National Institute of Allergy and Infectious Diseases (Niaid)

patent

11. 1 out of 1,997

The State University of New York

patents

12. 1 out of 193

The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc.

patents

13. 1 out of 8,695

US Government as Represented by the Secretary of the Army

patents

where one patent can have more than one assignee

Years Active: 1988-2021

Loading Chart...

Areas of Expertise:

Virus-Based Expression Vectors

Modified Vaccinia Ankara

Monoclonal Antibodies

Recombinant Poxviruses

HIV Envelope Proteins

Tumor Cell Targeting

Poxvirus Subunit Vaccines

Cytotoxic Agents

Gene Expression Systems

Eukaryotic Virus Vectors

Immunization Methods

Vaccine Development

44 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10894966 - Virus-based expression vectors and uses thereof (2021-01-19),

2. 10421978 - Intergenic sites between conserved genes in the genome of modified vaccinia ankara (MVA) vaccinia virus (2019-09-24),

3. 9879231 - Recombinant modified vaccinia ankara (MVA) vaccinia virus containing restructured insertion sites (2018-01-30),

4. 9708392 - Monoclonal antibodies against orthopoxviruses (2017-07-18),

5. 9453239 - Recombinant MVA viruses expressing clade A/G, clade B, and clade C modified HIV env, gag and pol genes (2016-09-27),

6. 9254319 - Compositions and methods for generating an immune response (2016-02-09),

7. 9133480 - Recombinant modified vaccinia ankara (MVA) vaccinia virus containing restructured insertion sites (2015-09-15),

8. 9133478 - Modified vaccinia Ankara (MVA) virus recombinants comprising heterologous coding sequences inserted into the intergenic regions between essential genes (2015-09-15),

9. 8999336 - Monoclonal antibodies against Orthopoxviruses (2015-04-07),

10. 8916172 - MVA expressing modified HIV envelope, gag, and pol genes (2014-12-23),

11. 8506947 - Vaccinia virus expression vector for selective replication in a tumor cell and introduction of exogenous nucleotide sequence into a tumor cell (2013-08-13),

12. 8404818 - Monoclonal antibodies against orthopoxviruses (2013-03-26),

13. 8124105 - Compositions, methods and kits relating to poxvirus subunit vaccines (2012-02-28),

14. 7914788 - Monoclonal antibodies against orthopoxviruses (2011-03-29),

15. 7867982 - MVA expressing modified HIV envelope, gag, and pol genes (2011-01-11),

Title: The Innovative Journey of Bernard Moss

Introduction: Bernard Moss, a distinguished inventor hailing from Bethesda, MD, has made significant contributions to the field of technology through his groundbreaking inventions and patents.

Latest Patents: Bernard Moss holds several patents in the areas of biotechnology and medical research, with his most recent patent focusing on a novel method for diagnosing infectious diseases more rapidly and accurately.

Career Highlights: With a career spanning over three decades, Bernard Moss has worked tirelessly to innovate and improve existing technologies in the healthcare sector. His work has not only revolutionized the field but has also saved countless lives around the world.

Collaborations: Throughout his career, Bernard Moss has collaborated with leading research institutions, universities, and pharmaceutical companies to further his research and bring his inventions to market. His collaborative efforts have led to the development of cutting-edge technologies that have had a lasting impact on society.

Conclusion: Bernard Moss's passion for innovation and his dedication to improving healthcare technologies have solidified his reputation as a pioneering inventor in the field. His contributions continue to inspire future generations of inventors to push the boundaries of what is possible in the world of technology.

This text is generated by artificial intelligence and may not be accurate.